Literature DB >> 18549799

The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation.

Avital Lev1, Kazuyo Takeda, Damien Zanker, Jason C Maynard, Peniel Dimberu, Elizabeth Waffarn, James Gibbs, Nir Netzer, Michael F Princiotta, Len Neckers, Didier Picard, Christopher V Nicchitta, Weisan Chen, Yoram Reiter, Jack R Bennink, Jonathan W Yewdell.   

Abstract

The nature of crosspriming immunogens for CD8(+) T cell responses is highly controversial. By using a panel of T cell receptor-like antibodies specific for viral peptides bound to mouse D(b) major histocompatibility complex class I molecules, we show that an exceptional peptide (PA(224-233)) expressed as a viral minigene product formed a sizeable cytosolic pool continuously presented for hours after protein synthesis was inhibited. PA(224-233) pool formation required active cytosolic heat-shock protein 90 but not ER g96 and uniquely enabled crosspriming by this peptide. These findings demonstrate that exceptional class I binding oligopeptides that escape proteolytic degradation are potent crosspriming agents. Thus, the feeble immunogenicity of natural proteasome products in crosspriming can be attributed to their evanescence in donor cells and not an absolute inability of cytosolic oligopeptides to be transferred to and presented by professional antigen-presenting cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18549799      PMCID: PMC2587262          DOI: 10.1016/j.immuni.2008.04.015

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  44 in total

Review 1.  Heat shock protein 90 as a molecular target for cancer therapeutics.

Authors:  Jennifer S Isaacs; Wanping Xu; Len Neckers
Journal:  Cancer Cell       Date:  2003-03       Impact factor: 31.743

2.  Heat-aggregated noninfectious influenza virus induces a more balanced CD8(+)-T-lymphocyte immunodominance hierarchy than infectious virus.

Authors:  Yunjung Cho; Sameh Basta; Weisan Chen; Jack R Bennink; Jonathan W Yewdell
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

3.  Cutting edge: efficient MHC class I cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells.

Authors:  Amparo Serna; Maria C Ramirez; Anna Soukhanova; Luis J Sigal
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

4.  A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation.

Authors:  Eric Reits; Joost Neijssen; Carla Herberts; Willemien Benckhuijsen; Lennert Janssen; Jan Wouter Drijfhout; Jacques Neefjes
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

5.  Cellular protein is the source of cross-priming antigen in vivo.

Authors:  Lianjun Shen; Kenneth L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

6.  Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.

Authors:  Satoshi Oizumi; Natasa Strbo; Savita Pahwa; Vadim Deyev; Eckhard R Podack
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

Review 7.  Rethinking peptide supply to MHC class I molecules.

Authors:  Laurence C Eisenlohr; Lan Huang; Tania N Golovina
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

Review 8.  Gap junction-mediated intercellular communication in the immune system.

Authors:  Joost Neijssen; Baoxu Pang; Jacques Neefjes
Journal:  Prog Biophys Mol Biol       Date:  2007-03-15       Impact factor: 3.667

9.  A lymphocytic choriomeningitis virus glycoprotein variant that is retained in the endoplasmic reticulum efficiently cross-primes CD8(+) T cell responses.

Authors:  Stefan Freigang; Bruno Eschli; Nicola Harris; Markus Geuking; Katharina Quirin; Sabrina Schrempf; Raphael Zellweger; Jacqueline Weber; Hans Hengartner; Rolf M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-08       Impact factor: 11.205

10.  Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines.

Authors:  Georg Gasteiger; Wolfgang Kastenmuller; Ronny Ljapoci; Gerd Sutter; Ingo Drexler
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

View more
  37 in total

1.  Heat shock protein 90 (HSP90) contributes to cytosolic translocation of extracellular antigen for cross-presentation by dendritic cells.

Authors:  Takashi Imai; Yu Kato; Chiaki Kajiwara; Shusaku Mizukami; Ikuo Ishige; Tomoko Ichiyanagi; Masaki Hikida; Ji-Yang Wang; Heiichiro Udono
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

Review 2.  Towards a systems understanding of MHC class I and MHC class II antigen presentation.

Authors:  Jacques Neefjes; Marlieke L M Jongsma; Petra Paul; Oddmund Bakke
Journal:  Nat Rev Immunol       Date:  2011-11-11       Impact factor: 53.106

Review 3.  Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come.

Authors:  Ayesha Murshid; Jianlin Gong; Mary Ann Stevenson; Stuart K Calderwood
Journal:  Expert Rev Vaccines       Date:  2011-11       Impact factor: 5.217

4.  MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA.

Authors:  Brian P Dolan; Aditi A Sharma; James S Gibbs; Tshaka J Cunningham; Jack R Bennink; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

5.  An invariant road to cross-presentation.

Authors:  Fei Duan; Pramod K Srivastava
Journal:  Nat Immunol       Date:  2012-02-16       Impact factor: 25.606

Review 6.  DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

Authors:  Jonathan W Yewdell
Journal:  Trends Immunol       Date:  2011-09-29       Impact factor: 16.687

Review 7.  Fishing for the hidden peptidome in health and disease (drug abuse).

Authors:  Lloyd D Fricker; Jonathan V Sweedler
Journal:  AAPS J       Date:  2010-09-18       Impact factor: 4.009

8.  Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action.

Authors:  Avital Lev; Michael F Princiotta; Damian Zanker; Kazuyo Takeda; James S Gibbs; Chiharu Kumagai; Elizabeth Waffarn; Brian P Dolan; Anne Burgevin; Peter Van Endert; Weisan Chen; Jack R Bennink; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

9.  Peptidomic analysis of HEK293T cells: effect of the proteasome inhibitor epoxomicin on intracellular peptides.

Authors:  Lloyd D Fricker; Julia S Gelman; Leandro M Castro; Fabio C Gozzo; Emer S Ferro
Journal:  J Proteome Res       Date:  2012-02-16       Impact factor: 4.466

10.  Peptidases released by necrotic cells control CD8+ T cell cross-priming.

Authors:  Jaba Gamrekelashvili; Tamar Kapanadze; Miaojun Han; Josef Wissing; Chi Ma; Lothar Jaensch; Michael P Manns; Todd Armstrong; Elizabeth Jaffee; Ayla O White; Deborah E Citrin; Firouzeh Korangy; Tim F Greten
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.